Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2021	Jun. 30, 2021
Current Assets
Cash	$ 4,099	$ 7,350
Total Current Assets	4,099	7,350
Other assets	115,000	115,000
Patent costs	39,181	39,181
Total Assets	158,280	161,531
Current Liabilities
Accounts payable and accrued expenses	16,393	14,528
Advances from related parties	38,022	16,241
Common stock payable	233,117	217,784
Total Current Liabilities	287,532	248,553
Stockholders’ Deficit
Common stock, $0.001 par value, 300,000,000 shares authorized; 5,295,582 and 5,239,832 shares issued at September 30, 2021 and June 30 2021	5,296	5,240
Additional paid-in-capital	9,191,461	9,174,792
Accumulated deficit	(9,326,017)	(9,267,062)
Total Stockholders’ Deficit	(129,252)	(87,022)
Total Liabilities and Stockholders' Deficit	158,280	161,531
Series A Preferred Stock [Member]
Stockholders’ Deficit
Preferred stock value	6	6
Series B Preferred Stock [Member]
Stockholders’ Deficit
Preferred stock value	$ 2	$ 2